4.7 Article

Sustained Systemic Inflammatory Response Predicts Survival in Patients with Hepatocellular Carcinoma After Hepatic Resection

Related references

Note: Only part of the references are listed.
Article Oncology

Postoperative Infectious Complications Worsen Long-Term Survival After Curative-Intent Resection for Hepatocellular Carcinoma

Tao Wei et al.

Summary: Postoperative infectious complications are independently associated with increased long-term risk of tumor recurrence and death among patients undergoing resection for hepatocellular carcinoma (HCC). Patients with non-surgical-site infection (SSI) have a particularly worse oncologic outcome compared to those with SSI.

ANNALS OF SURGICAL ONCOLOGY (2022)

Article Oncology

Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients

Kohei Yasui et al.

Summary: This study suggests that postoperative changes in inflammation-based prognostic markers are more accurate in predicting overall survival and recurrence-free survival in patients with stage III CRC. The study found that patients with a normalised inflammatory state had better prognosis compared to those with persistently elevated inflammatory state.

BRITISH JOURNAL OF CANCER (2021)

Review Oncology

Targeting cancer-promoting inflammation - have anti-inflammatory therapies come of age?

Jiajie Hou et al.

Summary: The immune system plays crucial roles in cancer development and treatment, with adaptive immunity capable of preventing or constraining cancer and innate immunity and inflammation often promoting tumorigenesis. While immunotherapies derived from preclinical studies have shown efficacy in treating cancer, treatments targeting cancer-associated inflammation still require successful implementation. Anti-inflammatory agents have the potential to delay cancer onset and enhance the efficacy of conventional and next-generation cancer therapies.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Effectiveness of Anatomical Resection for Small Hepatocellular Carcinoma: a Propensity Score-Matched Analysis of a Multi-institutional Database

Koichiro Haruki et al.

Summary: The study evaluates the significance of anatomical resection (AR) on therapeutic outcomes of patients with small hepatocellular carcinoma (HCC) using propensity score-matched (PSM) analysis. Results show that AR may improve disease-free survival in HCC patients with tumors of <= 5 cm diameter, with significantly lower liver remnant recurrence in the AR group.

JOURNAL OF GASTROINTESTINAL SURGERY (2021)

Article Gastroenterology & Hepatology

Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma

Salvatore Lorenzo Renne et al.

HEPATOLOGY (2020)

Review Immunology

Immune crosstalk in cancer progression and metastatic spread: a complex conversation

Hannah Garner et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Gastroenterology & Hepatology

The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma

Chandan Sanghera et al.

LIVER INTERNATIONAL (2019)

Article Gastroenterology & Hepatology

Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma

Masateru Yamamoto et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)

Review Immunology

NF-κB, inflammation, immunity and cancer: coming of age

Koji Taniguchi et al.

NATURE REVIEWS IMMUNOLOGY (2018)

Article Gastroenterology & Hepatology

Myeloid cells in hepatocellular carcinoma

Shanshan Wan et al.

HEPATOLOGY (2015)

Review Multidisciplinary Sciences

Origin and physiological roles of inflammation

Ruslan Medzhitov

NATURE (2008)

Article Gastroenterology & Hepatology

Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system

SM Strasberg

JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2005)